Thrombosis and Haemostasis

Article	Citations
COVID-19 Patients Putting on the Brakes with PAR1 Autoantibodies	107
	96
	87
Venous Thrombosis Associated with Different Types of SARS-CoV-2 Vaccines in the Netherlands—Results of the TERA Case-Control Study	78
Heparin and Direct Oral Anticoagulants have Different Effects on the Phases of Activation and Spatial Spread of Blood Coagulation	76
Commentary: “No Genetic Causality between Tobacco Smoking and Venous Thromboembolism: A Two-Sample Mendelian Randomization Study”	57
High anti-ADAMTS13 IgG Levels after Plasma Exchange Predict Delayed ADAMTS13 Normalization in Immune-mediated Thrombotic Thrombocytopenic Purpura	50
Platelet P2Y12 Inhibitor Monotherapy after Percutaneous Coronary Intervention: An Emerging Option for Antiplatelet Therapy De-escalation	48
Association between Clot Waveform Analysis Parameters and the Severity of Liver Cirrhosis	48
	44
Clinical and Genetic Characterization of 51 Patients with Congenital Fibrinogen Disorders from China	42
Heterogeneity in American and European Peripheral Artery Disease Guidelines on Non-statin Lipid-Lowering Therapy and Rivaroxaban	41
Predictors, Incidence, and Proximal Extension Rate of Distal Deep Vein Thrombosis in Internal Medicine Wards: Insights from the AURELIO Study	40
Atherosclerotic Autoantigen ALDH4A1 as a Novel Immunological Indicator for Plaque Erosion in Patients with ST Segment Elevated Myocardial Infarction	33
Assessing Clinically Meaningful Hypercoagulability after COVID-19 Vaccination: A Longitudinal Study	32
Agreement Between Classical and Two Automated Platelet Aggregometers in the Assessment of Response to Antiplatelet Therapy	29
Low Body Weight and Long-term Outcomes in Patients with Venous Thromboembolism: Insights from the COMMAND VTE Registry-2	29
Machine Learning-Based Predictive Models for Patients with Venous Thromboembolism: A Systematic Review	26
	25
	25
Risk of Bleeding in Liver Cirrhosis Receiving Direct Oral Anticoagulants: A Systematic Review and Meta-analysis	24
The Impact of Polypharmacy on the Effectiveness and Safety of Non-vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation	23
Survival Implications of Thrombus Recurrence or Bleeding in Cancer Patients Receiving Anticoagulation for Venous Thromboembolism Treatment	23
Volume Regulation and Nonosmotic Volume of Individual Human Platelets Quantified by High-Speed Scanning Ion Conductance Microscopy	23
A Rollercoaster Plunge into 2022	22

Cardiac Repair after Myocardial Infarction is Controlled by a Complement C5a Receptor 1-Driven Signaling Cascade	22
The Effect of Increasing Factor X Levels on Emicizumab-Driven Coagulation Potential	22
Methoxyflurane Instead of Morphine in Acute Coronary Syndrome Patients: Results of the Randomized Controlled METHANE-SIRIO 4 Study	21
Strategies for Tailored Antiplatelet Therapy after Percutaneous Coronary Intervention: Unraveling Complexities, Embracing Nuances	21
Statin Treatment and the Alterations in the Platelet Lipidome: What Is the Impact of Lipid Profile on Thrombosis?	21
Reflections on World Thrombosis Day 2024	21
Carotid Stenosis and Stroke: Medicines, Stents, Surgery—“Wait-and-See” or Protect?	20
Gaining Insights into Inherited Bleeding Disorders of Complex Etiology in Pediatric Patients: Whole-Exome Sequencing as First-Line Investigation Tool	20
3-Factor versus 4-Factor Prothrombin Complex Concentrates for the Reversal of Vitamin K Antagonist-Associated Coagulopathy: A Systematic Review and Meta-analysis	20
Challenges of Anticoagulation in an Obese Polytrauma Patient on Antifungals: A Case Report	19
Obesity and Pulmonary Embolism: Can We Dismantle the “Obesity Paradox”	19
Circulating Levels of Low-Density Granulocytes and Cell-Free DNA as Predictors of Cardiovascular Disease and Bone Deterioration in SLE Patients	19
Longitudinal In Vivo Monitoring of Atheroprogression in Hypercholesterolemic Mice Using Photoacoustic Imaging	18
Warfarin—Is Self-Care the Best Care?	18
Performance and Head-to-Head Comparison of Three Clinical Models to Predict Occurrence of Postthrombotic Syndrome: A Validation Study	18
Dose-Related Effectiveness of Andexanet Alfa for Reversal of Apixaban Anticoagulation in a Porcine Polytrauma Model	18
Are More Patients with Thromboembolic Disease Dying Now Than Before?	18
Von Willebrand Factor as a Therapeutic Target in Thrombotic Disorders	17
Risk of Incident Atrial Fibrillation and Subsequent Use of Oral Anticoagulants in Patients with Dementia	17
Characterization and Usefulness of Clot-Fibrinolysis Waveform Analysis in Critical Care Patients with Enhanced or Suppressed Fibrinolysis	16
Dual Antiplatelet Therapy or Dual Pathway Inhibition	16
Clopidogrel Monotherapy versus Aspirin Monotherapy in Patients with Established Cardiovascular Disease: Systematic Review and Meta-Analysis	16
Effectiveness and Safety of Oral Anticoagulants in the Treatment of Acute Venous Thromboembolism: A Nationwide Comparative Cohort Study in France	16
Enhancing Pulmonary Embolism Risk Stratification: The National Early Warning Score and Its Integration into the European Society of Cardiology Classification	15
Antithrombotic Prophylaxis with Rivaroxaban in Patients with Prehospital COVID-19: A Meta-analysis of Two Placebo-Controlled Trials	15
Anti-thrombotic Effects Mediated by a Novel Dual-Target Peptide Inhibiting Both Platelet Aggregation and Thrombin Activity without Causing Bleeding	15
Open Issues in the Choice and Management of Direct Oral Anticoagulants in Patients with Cancer-Related Venous Thromboembolism	15
D-Dimer Testing in the Emergency Department: Low Specificity and High Imaging Burden in Older and Comorbid Patients	15
Disseminated Intravascular Coagulation Score Predicts Mortality in Patients with Liver Disease and Low Fibrinogen Level	15
Clinical Delphi on aPL Negativization: Report from the APS Study Group of the Italian Society for Rheumatology (SIR-APS)	14
Emerging Thrombotic Disorders Associated with Virus-Based Innovative Therapies: From VITT to AAV Gene Therapy–Related Thrombotic Microangiopathy	14
Sensitivity to Aortic Rupture in Hereditary Aortic Diseases	14
N-Glycosylation Deficiency Reduces the Activation of Protein C and Disrupts Endothelial Barrier Integrity	13
Growth Differentiation Factor-15: A Novel Biomarker for Predicting Risk of Venous Thromboembolism and Bleeding in Patients with Cancer	13
Transfer RNAs are Linked to Ischemic Stroke and Major Bleeding in Patients with End-Stage Kidney Disease	13
Novel Immunochromatographic Test for Anti-factor XIII B Subunit Autoantibodies to Diagnose Autoimmune Acquired Factor XIII Deficiency	13
Pregnancy after Combined Oral Contraceptive-Associated Venous Thromboembolism: An International Retrospective Study of Outcomes	13
The Prognostic Value of the Age–D-Dimer–Albumin Score in Patients with Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention	13
Pulmonary Thromboembolism after Catheter Ablation of Cardiac Arrhythmias	13
Additional Factor X Enhances Emicizumab-Driven Coagulation Function in Patients with Hemophilia A and Hemophilia A Mice	13
CLEC-2 Supports Platelet Aggregation in Mouse but not Human Blood at Arterial Shear	13
From PE to CTEPH: Still Lost in Translation	12
Pathophysiological Aspects of COVID-19-Associated Vasculopathic Diseases	12
Thrombosis and Haemostasis 2022 Editors' Choice Papers	12
Usual On-therapy Ranges of Drug Concentrations in Patients with Atrial Fibrillation Treated with Direct Oral Anticoagulants: A Systematic Review and Meta-analysis	12
Inhibition of Hypoxia-Inducible Factor Prolyl-Hydroxylase Modulates Platelet Function	12
Impact of Age and NYHA Class on Clinical Outcomes of Fibrinolysis Versus Surgery in Prosthetic Valve Thrombosis: A Systematic Review and Meta-Regression	12
	12
Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase 1B Inhibition Promotes Megakaryocyte Polyploidization and Platelet Production	12
Inflammatory and Bleeding Risks on Clinical Outcomes in Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention	12

Risk Factors for Venous Thromboembolism in Women of Childbearing Age	12
Hyperresponsive Platelets and a Reduced Platelet Granule Release Capacity Are Associated with Severity and Mortality in COVID-19 Patients	12
Warfarin Use During Pregnancy in a Woman with Double Mechanical Valve Prostheses: Between Thrombosis and Teratogenicity	12
Hypercoagulability State in Predicting Severe Functional Outcome in Patients with Acute Ischemic Stroke: Cause, Consequence, or Both?	12
Early Time Courses of Recurrent Venous Thromboembolism and Bleeding during Apixaban or Dalteparin Therapy for Patients with Cancer	12
Association of Combined Lifestyle and Polygenetic Risk with Incidence of Venous Thromboembolism: A Large Population-Based Cohort Study	12
Continuous Improvement of Antiplatelet Therapy in Cardiovascular Disease	12
Expression of microRNA Predicts Cardiovascular Events in Patients with Stable Coronary Artery Disease	11
Diabetic Microvascular Disease and Risk of Peripheral Artery Disease, Foot Ulcer, Leg Infection, and Amputation	11
	11
Acquired Hemophilia A: The Essential Role of the Laboratory in Diagnosis	11
Functional Consequences of Antibodies against Noncatalytic B Subunit of Factor XIII	11
Current View on the Molecular Mechanisms Underlying Fibrin(ogen)-Dependent Inflammation	11
Activated Charcoal Neutralizes Xaban Interference In Vitro: A Practical and Efficient Approach	11
	11
Characterization of Arteriovenous Thrombus Formation and Propagation in a Mouse Arteriovenous Fistula Model	11
Clinical and Thrombotic Risk Profiles in Patients with HFpEF: Preliminary Insights from a Real-World Cohort	11
Impact of Plasminogen Activator Inhibitor-1 Homozygosity in Obstetric Context: Report of Three Clinical Cases	11
Cryofibrinogen—Characteristics and Association with Cryoglobulin: A Retrospective Study Out of a Series of 1,712 Samples over 7 Years	11
Extravascular Binding of Coagulation Factor IX Gives Hemostasis a Boost	11
	11
Acute Management of Vascular Stroke: Experience Report of Monocentric Private Expert Center in Morocco	11
SARS-CoV-2 Vaccination: Long-Term Follow-Up of Pre-existing and De Novo Immune Thrombocytopenia	11
Human Platelets Internalize Pregnancy-Specific Glycoprotein-1 (PSG1)	10
Anticoagulation in Patients with Isolated Distal Deep Vein Thrombosis: Bringing the Puzzle Together	10
Landscape and Spectrum of VWF Variants in Type 2 Von Willebrand Disease: Insights from a German Patient Cohort	10
Physical and Mechanobiological Basis of Biological Functions of Platelets	10
Brisk Walking Pace Offsets Venous Thromboembolism Risk Equivalent to Established Monogenic Mutations	10
Kidney Disease and Cancer Risk in Patients with Venous Thromboembolism: What Does It Mean for Clinical Practice?	10
Personalized Medicine, Public Health and Patient-Centred Aspects in the Prevention of Stroke in Intracerebral Haemorrhage Survivors with Atrial Fibrillation (PRESTIGE-AF) Project	10
Growth Differentiation Factor-15, High-Sensitivity Cardiac Troponin T, and N-Terminal pro-B-type Natriuretic Peptide for Predicting Risk of Venous Thromboembolism in Ambulatory Cancer Patients Receivi	10
Lymphoblasts Express Hemostatic Factors: A Mechanism for Hypercoagulability in Pediatric Acute Lymphoblastic Leukemia	9
Activation of the Acute-Phase Response in Hemophilia	9
Blood Loss in Women of Childbearing Potential Taking Oral Anticoagulants for Venous Thromboembolism (The BLEED Study)	9
Factor XI Inhibitors or Direct Oral Anticoagulants in Atrial Fibrillation: A Focused Meta-analysis	9
Pneumococcal Neuraminidases Increase Platelet Killing by Pneumolysin	9
Pharmacokinetics of Edoxaban 15 mg in Very Elderly Patients with Nonvalvular Atrial Fibrillation: A Subanalysis of the ELDERCARE-AF Study	9
Antithrombin Deficiency Is Associated with Prothrombotic Plasma Fibrin Clot Phenotype	9
Psychometric Validation of the Hemophilia Functional Ability Scoring Tool (Hemo-FAST)	9
External Validation of the Patient-Reported Villalta Scale for the Diagnosis of Postthrombotic Syndrome	9
Impairment of Collagen-Induced Thrombus Formation in Microfluidic Assay Correlates with Bleeding Complications Better Than Cytofluorometric Parameters	9
Bacterial-Type Long-Chain Polyphosphates Bind Human Proteins in the Phosphatidylinositol Signaling Pathway	9
Vaccine-Induced Immune Thrombotic Thrombocytopenia Two Years Later: Should It Still Be on the Scientific Agenda?	8
Compromised PAR1 Activation—A Cause for Bleeding in XMEN?	8
Not Just CTEPH: A Narrative Review on the Spectrum Approach to Postpulmonary Embolism Conditions	8
Resting Heart Rate and Risk of Incident Venous Thromboembolism: The Tromsø Study	8
Risk Factors for Postdischarge Major Thromboembolism and Mortality in Hospitalized Patients with COVID-19 with Cardiovascular Comorbidities: Insights from the CORE-19 Registry	8
Early Cardiorenal Risk Factors in Patients with Preserved eGFR: Integration of Vascular and Renal Biomarkers	8
Predicting Bleeding in Cancer-Associated Venous Thromboembolism: Another Milestone Achieved	8
	8
Exploring Causal Relationships between Circulating Inflammatory Proteins and Thromboangiitis Obliterans: A Mendelian Randomization Study	8
Cost-Effectiveness of Performing Reference Ultrasonography in Patients with Deep Vein Thrombosis	8
Occult Malignant Disease: The Saga of Multiple Thromboembolic Events	8
Blood Coagulation and Beyond: Position Paper from the Fourth Maastricht Consensus Conference on Thrombosis	8
Continuous Infusion of Factor VIII and von Willebrand Factor in Surgery: Trials with pdFVIII LFB or pdVWF LFB in Patients with Bleeding Disorders	8
	8
Case Report: Acquired Von Willebrand Disease Secondary to Chronic Lymphocytic Leukemia	7
Prevention of Stroke in Intracerebral Haemorrhage Survivors with Atrial Fibrillation: Rationale and Design for PRESTIGE-AF Trial	7
The Role of Oxidative Stress and MicroRNAs in Platelet Activation and the Efficacy of Antiplatelet Therapy in Acute Myocardial Infarction	7
Addendum: Sex as a Risk Factor for Atrial Fibrillation-Related Stroke	7
Final Analysis Results from the AGEHA Study: Emicizumab Prophylaxis for Acquired Hemophilia A with or without Immunosuppressive Therapy	7
Usefulness and Limits of DOAC Removal Agents Based on Activated Charcoal in Thrombophilia Testing: Literature Review and Expert Proposals	7
Ethnic Differences in Thrombotic Profiles of Acute Coronary Syndrome Patients and Relationship to Cardiovascular Outcomes: A Comparison of East Asian and White subjects	7
The Association between Obstructive Sleep Apnea and Venous Thromboembolism: A Bidirectional Two-Sample Mendelian Randomization Study	7
High-Resolution Spatial Profiling Unveils Cellular Heterogeneity in Murine Atherosclerosis	7
	7
Effectiveness and Safety of Apixaban versus Rivaroxaban in Patients with Atrial Fibrillation and Type 2 Diabetes Mellitus	7
Potential of Sulodexide in the Treatment of Diabetic Retinopathy and Retinal Vein Occlusion	7
Racial Differences in Bleeding Risks among Patients with Atrial Fibrillation: An Ecological Epidemiological Study Comparing Korea and UK Population	7
The Role of Clot Waveform Analysis and Related Parameters in the Diagnosis and Treatment of Hemophilia A	7
	7
COVID-19 and Long-COVID Thrombosis: From Clinical and Basic Science to Therapeutics	7
Relationship Between Screening-Detected Atrial Fibrillation and Blood Pressure Levels in Elderly Hypertensive Patients: The OMRON Heart Study	7
Utility of Sepsis-induced Coagulopathy Among Disseminated Intravascular Coagulation Diagnostic Criteria: A Multicenter Retrospective Validation Study	7
Reticulated Platelets: A Promising Prognosis Marker in Cardiovascular Diseases	7
Lack of Formyl-peptide Receptor 1 Mitigates Atherosclerosis in Hyperlipidemic Mice	7
Patterns and Persistence of Anticoagulant Use in the Treatment of Venous Thromboembolism: Insights from South Korea	7
Navigating Anticoagulation in Ischemic Left Ventricular Aneurysms: Lessons from Cardiac Magnetic Resonance Imaging	7
Free Fatty Acids Link Residual Lipid and Thrombotic Risk via Impairment of Aspirin Antiplatelet Effects	6
	6

	6
	6
The Risk of Incident Venous Thromboembolism Attributed to Overweight and Obesity: The Tromsø Study	6
Pharmacological Inhibition of Glycoprotein VI- and Integrin α2β1-Induced Thrombus Formation Modulated by the Collagen Type	6
Thrombosis Caused by Factor XI Gly397Ser Mutation with Enhanced Procoagulant Activity	6
Trypsin Activates Human Platelets via Proteolytic Cleavage of Protease-Activated Receptor 4	6
	6
Neutrophil Extracellular Traps in the Infarct-Related Coronary Artery—A Marker or Mediator of Adverse Outcome?	6
Hyperfibrinolysis is Associated with Complement Activation Following Trauma	6
Risk Factors of Cardiovascular Death after Venous Thromboembolism: Results from a Prospective Cohort Study	6
Novel Insights into the Aortic Mechanical Properties of Mice Modeling Hereditary Aortic Diseases	6
The Effect of Protease-Activated Receptor-1 (PAR-1) Inhibition on Endothelial-Related Biomarkers in Patients with Coronary Artery Disease	6
Blood Levels and Composition of Leukocyte–Platelet Aggregates in Inflammatory Diseases of Various Etiologies	6
De-escalation of DAPT—A Potential Strategy for Treating Ticagrelor-Related Dyspnea?	6
	6
Educational Attainment, Obesity, and Venous Thromboembolism. Is Only Matter of Weight?	6
	6
One Year Prevalence of Venous Thromboembolism in Hospitalized COVID-19 Patients in France: Patients' Characteristics, Time Trends, and Outcomes	6
Elevated Thrombin Generation and Venous Thromboembolism Incidence in Patients Undergoing Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy Compared with Minimally Invasive Rectal Su	6
Association of Specific Antiphospholipid Antibodies to Platelet Count and Thrombocytopenia	5
Adverse Events and All-Cause Mortality in Danish Patients with Cerebral Venous Thrombosis: A Nationwide Cohort Study	5
Thrombotic Events after Prothrombin Complex Administration in Chronic Liver Disease and Cirrhosis Patients: A Tertiary Care Hospital Retrospective Study	5
Factor XIII-A Transglutaminase Contributes to Neutrophil Extracellular Trap (NET)-mediated Fibrin(ogen) Network Formation and Crosslinking	5
Derivation and Validation of a COPD-specific Pulmonary Embolism Diagnostic Strategy	5
Unravelling the Causal Relationship between Endometriosis and the Risk for Developing Venous Thromboembolism: A Pooled Analysis	5
	5
Association of Fibrinogen Variants with Severity of Obesity and Metabolic Liver Disease: 2-Year Follow-up after Bariatric Surgery	5
	5
State-of-the-Art Mini Review: Dual-Pathway Inhibition to Reduce Arterial and Venous Thromboembolism	5
Recurrent Thrombosis Under Therapeutic Anticoagulation as the First Sign of Occult Gastric Cancer	5
Altered HDL Proteomic Profile Reflects Enhanced Atherothrombotic Risk in Familial Hypercholesterolemia	5
An International Consensus Practical Guide on Left Atrial Appendage Closure for the Non-implanting Physician: Executive Summary	5
Performance of Bleeding Risk Scores for Major Bleeding in Anticoagulated Patients with Pulmonary Embolism: Insights from the CURES Registry-2	5
Antiplatelet Therapy in Percutaneous Coronary Intervention Patients with Concurrent High Ischemic and Bleeding Risk	5
Ser252Asn Mutation Introduces a New N-Linked Glycosylation Site and Causes Type IIb Protein C Deficiency	5
CXCL2 Mediates Lactate Secretion and Promotes Aortic Dissection Formation through the p38/JNK/C-myc Pathways	5
Effect of Alirocumab Added to High-Intensity Statin on Platelet Reactivity and Noncoding RNAs in Patients with AMI: A Substudy of the PACMAN-AMI Trial	5
Relationship of JAK2 Mutation Burden with Thrombosis and Survival in Polycythemia Vera	5
Concomitant Use of Selective Serotonin Reuptake Inhibitors and Oral Anticoagulants and Risk of Major Bleeding: A Systematic Review and Meta-analysis	5
Venous Thromboembolism Post-allogeneic Hematopoietic Cell Transplant: Risk Factors, Incidence, and Outcomes	5
CM-352 Efficacy in a Mouse Model of Anticoagulant-Associated Intracranial Hemorrhage	5
A Happy New Year 2024 from Thrombosis and Haemostasis!	5
Platelet Aggregation Is Not Altered in Men with Aortic Aneurysms	5
Comparison of De-escalation of DAPT Intensity or Duration in East Asian and Western Patients with ACS Undergoing PCI: A Systematic Review and Meta-analysis	4
Left Atrial Spontaneous Echo Contrast: Pathogenesis, Detection, and Modelling	4
	4
Outcomes of Patients with a Mechanical Heart Valve and Poor Anticoagulation Control on Warfarin	4
Reversible Thrombocytopenia of Functional Platelets after Nose-Horned Viper Envenomation is Induced by a Snaclec	4
Joint Effect of Multiple Prothrombotic Genotypes and Mean Platelet Volume on the Risk of Incident Venous Thromboembolism	4
Platelet Activation via Glycoprotein VI Initiates Thrombin Generation: A Potential Role for Platelet-Derived Factor IX?	4
D-β-Hydroxybutyrate Dehydrogenase Mitigates Diabetes-Induced Atherosclerosis through the Activation of Nrf2	4
Identification of Factor XIII β-Sandwich Residues Mediating Glutamine Substrate Binding and Activation Peptide Cleavage	4
Time Trends and Excess Mortality Compared to Population Controls after a First-Time Pulmonary Embolism or Deep Vein Thrombosis	4
Clinical Impact of Dyspnea after Ticagrelor Treatment and the Effect of Switching to Clopidogrel in Patients with Myocardial Infarction	4
Stress, Partner Violence, and Coagulopathy: Unmasking New Triggers for Venous Thromboembolism	4
Impact of Fibrinogen Infusion on Thrombin Generation and Fibrin Clot Structure in Patients with Inherited Afibrinogenemia	4
	4
Venous Thromboembolism Associated with Assisted Reproductive Technology: A Systematic Review and Meta-analysis	4
DNA Methylation and Ischemic Stroke Risk: An Epigenome-Wide Association Study	4
Association between Sports Participation, Factor VIII Levels and Bleeding in Hemophilia A	4
	4
Impact of ABO Blood Group on Thromboembolic and Bleeding Complications in Patients with Left Ventricular Assist Devices	4
Knockdown of tmem183a in Zebrafish Causes Thrombocytopenia and Reduces Coagulation Factors, Disrupting Hemostasis	4
Racial Differences in Bleeding Risk: An Ecological Epidemiological Study Comparing Korea and United Kingdom Subjects	4
An Inhibitory Single-Domain Antibody against Protein Z-Dependent Protease Inhibitor Promotes Thrombin Generation in Severe Hemophilia A and FXI Deficiency	4
Field Study and Correlative Studies of Factor IX Variant FIX-R338L in Participants Treated with Fidanacogene Elaparvovec	4
Major Bleeding Risk During Concomitant Use of Antiarrhythmic Drugs and Oral Factor Xa Inhibitors: A Nationwide Self-Controlled Case Series Study	4
Venous Thromboembolism Outcomes Among Cancer and Non-cancer Patients Managed with Patient-centric Guideline-driven Protocol	4
Heparin-Induced Thrombocytopenia Managed with a Direct Oral Anticoagulant: A Case Report	4
	4
HemosIL VWF:GPIbR Assay Has a Greater Sensitivity than VWF:RCo Technique to Detect Acquired von Willebrand Syndrome in Myeloproliferative Neoplasms	4
Laboratory Monitoring of UFH in Different Settings (DEXHEP Study): Association between Anti-Xa Levels, Platelet Factor 4 (PF4) Plasma Levels and Dextran Sulfate	4
	4
Comparison of Clinical Outcomes in Patients with Active Cancer Receiving Rivaroxaban or Low-Molecular-Weight Heparin: The OSCAR-UK Study	4
Selective Serotonin Reuptake Inhibitor Use and Risk of Major Bleeding during Treatment with Vitamin K Antagonists: Results of A Cohort Study	4
Clinical and Laboratory Presentation and Underlying Mechanism in Patients with Low VWF	4
Direct Oral Anticoagulants versus Standard Therapy in Upper Extremity Deep Vein Thrombosis: Real-World Evidence	4
Structural Conformation and the Binding of Factor VIII R2159C (FVIII-Ise) Mutated in the C1 Domain to Phospholipid	4
Causal Effects of COVID-19 on the Risk of Thrombosis: A Two-Sample Mendel Randomization Study	4
How Did We Get Here? Antithrombotic Therapy after Bioprosthetic Aortic Valve Replacement: A Review	4
C-reactive Protein, Genetic Susceptibility, and the Long-Term Risk of Venous Thromboembolism in Patients with Past Cancer	4
Increased von Willebrand Factor Platelet-Binding Capacity Is Related to Poor Prognosis in COVID-19 Patients	4
Factor Xa Inhibitor Plasma Concentrations and Clinical Outcomes in Patients Weighing ≤50 kg—Experience from Four UK Centers	3
Circulating Blood Biomarkers and Risk of Venous Thromboembolism in Cancer Patients: A Systematic Review and Meta-Analysis	3
	3
ANGWC Nomogram for Predicting Poor 3-month Outcome after Intravenous Thrombolysis in Young and Middle-aged Patients with First-ever Stroke	3
Gene Correction of Wiskott–Aldrich syndrome iPS Cells Rescues Proplatelet Defects and Improves Platelet Size	3
Incidence and Outcomes Associated with 6,841 Isolated Distal Deep Vein Thromboses in Patients with 13 Common Cancers	3
Low α-Thrombin/GPIbα Interaction Is a Potential Contributor to Platelet Hyper-reactivity in COVID-19 Patients	3
	3
Bleeding Propensity in Waldenström Macroglobulinemia: Potential Causes and Evaluation	3
Treatment Modifications in Acute Coronary Syndrome Patients Treated with Ticagrelor: Insights from the FORCE-ACS Registry	3
Dynamics of Thrombogenicity and Platelet Function and Correlation with Bleeding Risk in Patients Undergoing M-TEER Using the PASCAL System	3
Endothelial Damage in JAK2V617F Myeloproliferative Neoplasms with Splanchnic Vein Thrombosis	3
The Hard Bargain of Anticoagulation after Intracranial Hemorrhage, in the Setting of Venous Thromboembolism: Between a Rock and a Hard Place	3